CytoSorbents Corporation (CTSO)

[caesare74]

Techxen, many tks. I'm fully with you about the figures. IMO Cytosorb wants also to have a broader base of shareholders. Additional cash to fund a much more agressive growth than planned (this I heard from a sales rep. of Fresenius Medical) would require more cash. Depends on the market conditions, it will be an extension of the loan and/or capital increase. I guess it will be a combination of both. The annoucement will be early Jan. 2019 (?). Assuming they will be profitable (excl. clinical tests) by Q4-2018, they still will need cash to fund agressively future sales. Chan's statement "we have enough cash till 2021 to fund the clinical trials, is right in terms of a non agressive sales strategy. But Kathleen Bloch mentioned in her recent statement, that she might be looking into a further cash injection to push sales more agressively. I see this as very positive. Thus, CTSO is financially in a much better position when they finally get the FDA in 2021 or ev. earlier. A partnership with a big pharma (to be announced in Jan./Feb. 2019 IMO) along with the support of
Dr. Carl June, will speed up the FDA approval process IMO.